Palliative and prognostic approach in cancer patients identified in the multicentre NECesidades PALiativas 2 study in Argentina [0.03%]
阿根廷NECesidades PALiativas 2多中心研究中癌症患者预后和姑息治疗方法的研究
Vilma Adriana Tripodoro,Victoria Llanos,María Laura Daud et al.
Vilma Adriana Tripodoro et al.
Background: Early identification of palliative needs has proven benefits in quality of life, survival and decision-making. The NECesidades PALiativas (NECPAL) Centro Coordinador Organización Mundial de la Salud - Institu...
Nursing diagnoses among oncology patients in medical units: a retrospective study of patients' records [0.03%]
内科病房肿瘤患者的护理诊断:对患者病历的回顾性研究
Elham H Othman,Mohammad R Alosta,Jafar Alasad Alshraideh et al.
Elham H Othman et al.
Objective: Nursing care plans for oncology patients are complex and overlapping enough to warrant the need for systematised documentation that ensures high quality, flawless and comprehensive care. Addressing the patients...
Defining the correlation between immune-checkpoint inhibitors-related adverse events and clinical outcomes: a narrative review [0.03%]
界定免疫检查点抑制剂相关不良事件与临床结局之间关系的影响因素:叙事综述
Omar Abdihamid,Abeid Omar,Tibera Rugambwa
Omar Abdihamid
Immune checkpoint inhibitors (ICIs) have increased modern anticancer armamentarium portfolios, with 15%-60% of cancer patients deriving clinical benefit while others progress, including some occurrences of accelerated progressions. ICIs hav...
Determinants of completion of cancer directed treatment: an experience from a rural cancer centre, Sangrur, Punjab state, India [0.03%]
印度旁遮普省桑格鲁农村癌症中心癌症导向治疗完成情况的影响因素:一项经验研究
Atul M Budukh,Debashish Chaudhary,Sankalp Sancheti et al.
Atul M Budukh et al.
In low and middle-income countries, access to cancer diagnosis and treatment is suboptimal. Further, compliance to cancer treatment is a major issue due to various reasons including financial barriers, lack of family support and fear of tre...
Implementation of a molecular tumour board in LATAM: the impact on treatment decisions for patients evaluated at Instituto Alexander Fleming, Argentina [0.03%]
拉美地区分子肿瘤委员会的实施:阿根廷亚历山大弗莱明研究所评估患者的治疗决策影响
Martín Osvaldo Angel,Carmen Pupareli,Tomas Soule et al.
Martín Osvaldo Angel et al.
Background: The role of the molecular tumour board (MTB) is to recommend personalised therapy for patients with cancer beyond standard-of-care treatment. A comprehensive molecular analysis of the tumour in a molecular pat...
Extreme oncoplasty for centrally located breast cancer in small non-ptotic breasts: extending the indications of chest wall perforator flaps with areolar reconstruction [0.03%]
小乳乳房中央型乳腺癌的极端整形术:扩大穿支皮瓣乳头乳晕复合体重建的适用范围
Shashank Nigam,Andrew Eichholz,Madhu Bhattacharyya et al.
Shashank Nigam et al.
Background: Breast cancers located centrally require excision of nipple-areola complex. A simple central wide excision is a safe option but results in suboptimal aesthetic outcome. An oncoplastic option involves therapeut...
Knowledge, preferences and willingness to use at-home prostate and colorectal cancer screening tests in African American and Haitian men [0.03%]
非洲裔美国人和海地男性对在家前列腺癌和结直肠癌筛查测试的知识,偏好及使用意愿
Alexandra Jean-Louis,Fern J Webb
Alexandra Jean-Louis
Haitian (HA) and African American (AA) men have the highest prostate cancer (PCa) and colorectal cancer (CRC) age-adjusted mortality rates compared with other racial/ethnic groups worldwide. One contributing factor to mortality differences ...
Comparison of health access, lifestyle, prostate cancer knowledge and screening among black men residing in West Africa and the USA [0.03%]
居住在西非和美国的黑人男子对健康通道,生活方式,前列腺癌认知及筛查的对比研究
Orlando Rivera Colón,Opeyemi Bolajoko,Folakemi Odedina et al.
Orlando Rivera Colón et al.
Background: In Blacks, late presentation, lack of knowledge, health infrastructural deficiencies and socio-demographic characteristics, which result in poor outcomes, are the bane of cancers. This study evaluated health a...
Impact of stigma and stigma-focused interventions on screening and treatment outcomes in cancer patients [0.03%]
癌症患者中污名的影响以及以污名为焦点的干预措施对筛查和治疗结局的作用
Elizabeth O Akin-Odanye,Anisah J Husman
Elizabeth O Akin-Odanye
Background: Stigma is known to negatively influence cancer patients' psychosocial behaviour and treatment outcomes. The aim of this study was to systematically review the current data on cancer-related stigma across diffe...
Jordan Swaby,Ernie Kaninjing,Motolani Ogunsanya
Jordan Swaby
Background: According to the Food and Drug Administration, African Americans (AAs) have been habitually underrepresented in cancer clinical trials (CCTs). This under-enrolment has contributed to cancer disparities despite...